Skip to main content
Log in

Debate: Molecular cardiac imaging is ready for the prime time con between wishful thinking and reality

  • Debate Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Mankoff DA. A definition of molecular imaging. J Nucl Med 2007;48:18N.

    PubMed  Google Scholar 

  2. Decristoforo C, Peñuelas I, Elsinga P, Ballinger J, Winhorst A, Verbruggen A, et al. Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals. Eur J Nucl Med Mol Imaging 2014;41:2005-7.

    Article  CAS  PubMed  Google Scholar 

  3. Camici PG. Imaging of cardiac adrenergic innervation. Heart 2002;88:209-10.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Haubner R, Beer AJ, Wang H, Chen X. Positron emission tomography tracers for imaging angiogenesis. Eur J Nucl Med Mol Imaging 2010;37:S86-103.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Wu C, Li F, Niu G, Chen X. PET imaging of inflammation biomarkers. Theranostics 2013;3:448-66.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Nahrendorf M, Sosnovik DE, French BA, Swirski FK, Bengel F, Sadeghi MM, et al. Multimodality cardiovascular molecular imaging. Part II. Circ Cardiovasc Imaging 2009;2:56-70.

    Article  PubMed Central  PubMed  Google Scholar 

  7. Boellard R, Delgado-Bolton R, Oyen W, Giammarile F, Tatsch K, et al. FDG PET/CT: EANM procedural guidelines version 2.0. Eur J Nucl Med Mol Imaging 2015, in press.

  8. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden Ch. 2013 ESC Guidelines on the management of stable coronary artery disease. Eur Heart J 2013;34:2949-3003.

    Article  PubMed  Google Scholar 

  9. Erbel R, Aboyans V, Boileau C, Bosone E, Bartolomeo R, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J 2014;35:2873-926.

    Article  PubMed  Google Scholar 

  10. McMurray J, Adamopoulos S, Anker S, Auricchio A, Boehm M, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2012;33:1787-847.

    Article  PubMed  Google Scholar 

  11. Gladding P, Cave A, Zareian M, Smith K, Hussan J, et al. Open access integrated therapeutic and diagnostic platforms for personalized cardiovascular medicine. J Personal Med 2013;3:2013-237.

    Google Scholar 

  12. Kirchhof P, Sipido KR, Cowie MR, Eschenhagen T, Fox KAA, et al. The continuum of personalized cardiovascular medicine: A position paper of the European Society of Cardiology. Eur Heart J 2014;35:3250-7.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Mullard A. In 2012 FDA drug approvals. Nat Rev Drug Discov 2013;12:87-90.

    Article  PubMed  Google Scholar 

  14. Joshi NV, Vesey AT, Williams MC, Shah AS, Calvert PA, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: A prospective clinical trial. Lancet 2014;383:705-13.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ignasi Carrió MD, FESC, FRCP.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carrió, I. Debate: Molecular cardiac imaging is ready for the prime time con between wishful thinking and reality. J. Nucl. Cardiol. 23, 64–66 (2016). https://doi.org/10.1007/s12350-015-0124-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-015-0124-5

Keywords

Navigation